IsoRay Inc Alpha and Beta Analysis
| ISRDelisted Stock | USD 0.38 0.01 2.70% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as IsoRay Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in IsoRay over a specified time horizon. Remember, high IsoRay's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to IsoRay's market risk premium analysis include:
Beta (1.37) | Alpha 0.53 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
IsoRay |
IsoRay Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. IsoRay market risk premium is the additional return an investor will receive from holding IsoRay long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IsoRay. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate IsoRay's performance over market.| α | 0.53 | β | -1.37 |
IsoRay Fundamentals Vs Peers
Comparing IsoRay's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze IsoRay's direct or indirect competition across all of the common fundamentals between IsoRay and the related equities. This way, we can detect undervalued stocks with similar characteristics as IsoRay or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of IsoRay's fundamental indicators could also be used in its relative valuation, which is a method of valuing IsoRay by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare IsoRay to competition |
| Fundamentals | IsoRay | Peer Average |
| Return On Equity | -0.17 | -0.31 |
| Return On Asset | -0.11 | -0.14 |
| Profit Margin | (1.16) % | (1.27) % |
| Operating Margin | (1.21) % | (5.51) % |
| Current Valuation | (11.02 M) | 16.62 B |
| Shares Outstanding | 278.66 M | 571.82 M |
| Shares Owned By Insiders | 0.76 % | 10.09 % |
IsoRay Opportunities
IsoRay Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Brachytherapy Market Is Expected to Generate USD 1.6 Billion by 2031, Says Allied Market Research - Benzinga | 01/27/2023 |
2 | Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc. | 02/07/2023 |
3 | IsoRay Fiscal Q2 Earnings Snapshot | 02/16/2023 |
About IsoRay Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including IsoRay or other delisted stocks. Alpha measures the amount that position in IsoRay Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
IsoRay Upcoming Company Events
As portrayed in its financial statements, the presentation of IsoRay's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, IsoRay's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of IsoRay's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of IsoRay. Please utilize our Beneish M Score to check the likelihood of IsoRay's management manipulating its earnings.
| 9th of May 2023 Upcoming Quarterly Report | View | |
| 27th of September 2023 Next Financial Report | View | |
| 31st of March 2023 Next Fiscal Quarter End | View | |
| 27th of September 2023 Next Fiscal Year End | View | |
| 31st of December 2022 Last Quarter Report | View | |
| 30th of June 2022 Last Financial Announcement | View |
Build Portfolio with IsoRay
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in IsoRay Stock
If you are still planning to invest in IsoRay Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoRay's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |